www.nytimes.com/2015/11/15/magazine/the-crispr-quandary.html?smid=fb-nytscience&smtyp=cur&_r=1
www.popsci.com/biotech-company-will-use-crispr-on-people-in-next-two-years
Leveraging the power of the microbiome – a new source for targeted cancer therapy – MedCity NewsMedCity News
0 0
[...]
mobile.nytimes.com/blogs/bits/2015/11/05/why-health-care-start-ups-like-theranos-need-investing-expertise/?_r=0&referer=https://www.google.co.uk/
VC Deals (12 deals, $109M raised) TAI Diagnostics Inc., a Wauwatosa, Wis.-based developer of diagnostic tests for monitoring the health of transplanted organs, has raised $8.2 million in Series A [...]
http://www.technologyreview.com/news/543181/crispr-gene-editing-to-be-tested-on-people-by-2017-says-editas/?utm_campaign=socialsync&utm_medium=social-post&utm_source=facebook
www.wsj.com/articles/jessica-richman-wants-people-to-track-their-microbiomes-1445911357
VC Deals (14 deals, $480M) HealthiPASS, a Chicago-based patient check-in and payments company, has raised an undisclosed amount of Series A funding. OCA Ventures led the round, and was joined by [...]
VC Deals Doctolib, a French platform for booking doctor appointments, has raised €18 million in Series B funding led by Accel Partners FabFitFun, a Los Angeles-based “lifestyle brand inspiring [...]
http://www.nasdaq.com/article/dupont-caribou-biosciences-form-strategic-collaboration-cm530182